FDA Clears Another Zika Assay, Luminex's xMap

The xMap Multiflex Zika RNA Assay is a molecular diagnostic that is designed to detect the Zika virus in human serum, urine or plasma.

The US FDA announced the clearance of another Zika assay Aug. 4, Luminex Corp.’s xMap Multiflex Zika RNA Assay.

The test carries an indication for use of detecting the Zika virus in human serum, plasma and urine. The assay must be conducted in labs certified under the Clinical Laboratory...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America